Inventiva S.A

Price Chart

Risk-Adjusted Performance

Also Listed On

Inventiva S.A (IVA) Price Performance

Inventiva S.A (IVA) trades on Euronext Paris in EUR. The company is classified in the Healthcare sector under the Biotechnology industry. The stock currently trades at EUR5.20, up 1.76% from the previous close.

Over the past year, IVA has traded between a low of EUR2.57 and a high of EUR5.98. The stock has gained 89.1% over this period. It is currently 13.0% below its 52-week high.

Inventiva S.A has a market capitalization of $1.13B.

About Inventiva S.A

Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other diseases in France and internationally. The company develops Lanifibranor, a novel pan-peroxisome proliferator-activated receptor agonist that is in the NATiV3 Phase 3 clinical trial to treat adult patients with MASH; and Odiparcil for the treatment of patients with mucopolysaccharidoses. It also develops TGF-ß, a pre-clinical program for the treatment of idiopathic pulmonary fibrosis. The company was incorporated in 2011 and is headquartered in Daix, France.